WallStreetZenWallStreetZen

NASDAQ: FLGT
Fulgent Genetics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

FLGT past revenue growth

How has FLGT's revenue growth performed historically?
Company
-53.27%
Industry
0.38%
Market
17.61%
FLGT's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
FLGT's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
FLGT's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

FLGT earnings and revenue history

Current Revenue
$289.2M
Current Earnings
-$167.8M
Current Profit Margin
-58%

FLGT Return on Equity

Current Company
-13.6%
Current Industry
-24%
Current Market
188%
FLGT's Return on Equity (-13.6%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when FLGT announces earnings.

FLGT Return on Assets

Current Company
-12.6%
Current Industry
6.7%
FLGT is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

FLGT Return on Capital Employed

Current Company
-14.34%
Current Industry
11.6%
FLGT's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

FLGT vs Diagnostic & Research Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
FLGT$289.21M-$134.12M-$167.83M+68.41%N/A
CSTL$219.79M-$45.02M-$57.47M+57.35%N/A
LAB$106.34M-$65.66M-$74.66M-1.20%N/A
CDNA$280.32M-$182.19M-$190.28M+29.63%N/A
OPK$863.50M-$65.62M-$188.86M-2.70%N/A
View Top Diagnostic & Research Stocks

FLGT earnings dates

Next earnings date
May 3, 2024

Fulgent Genetics Earnings & Revenue FAQ

What were FLGT's earnings last quarter?

On Invalid Date, Fulgent Genetics (NASDAQ: FLGT) reported Q4 2023 earnings per share (EPS) of -$4.30, up 458.44% year over year. Total Fulgent Genetics earnings for the quarter were -$128.15 million. In the same quarter last year, Fulgent Genetics's earnings per share (EPS) was -$0.77.

If you're new to stock investing, here's how to buy Fulgent Genetics stock.

What was FLGT's earnings growth in the past year?

As of Q2 2024, Fulgent Genetics's earnings has grown year over year. Fulgent Genetics's earnings in the past year totalled -$167.83 million.

What is FLGT's earnings date?

Fulgent Genetics's earnings date is Invalid Date. Add FLGT to your watchlist to be reminded of FLGT's next earnings announcement.

What was FLGT's revenue last quarter?

On Invalid Date, Fulgent Genetics (NASDAQ: FLGT) reported Q4 2023 revenue of $70.51 million up 4.14% year over year. In the same quarter last year, Fulgent Genetics's revenue was $67.70 million.

What was FLGT's revenue growth in the past year?

As of Q2 2024, Fulgent Genetics's revenue has grown -53.27% year over year. This is 53.66 percentage points lower than the US Diagnostics & Research industry revenue growth rate of 0.38%. Fulgent Genetics's revenue in the past year totalled $289.21 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.